查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1544024

聚合酵素链锁反应的全球市场

Polymerase Chain Reaction
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球聚合酵素链锁反应市场预计将达到 131 亿美元

全球聚合酵素链锁反应市场预计2023年为93亿美元，预计到2030年将达到131亿美元，2023年至2030年复合年增长率为5.0%。 PCR 仪器是本报告分析的细分市场之一，预计复合年增长率为 4.9%，到分析期结束时将达到 34 亿美元。分析期间，PCR 试剂及耗材领域的复合年增长率预计为 5.0%。

美国市场预估为25亿美元，中国预期复合年增长率为7.6%

预计 2023 年美国聚合酵素链锁反应市场规模将达 25 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达29亿美元，2023-2030年分析期间复合年增长率为7.6%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.7% 和 4.4%。在欧洲，德国的复合年增长率预计为 2.9%。

全球聚合酵素链锁反应市场 - 主要趋势与驱动因素总结

聚合酵素链锁反应：现代分子生物学的基石

聚合酵素链锁反应(PCR) 是分子生物学中的一项革命性技术，可以扩增特定的 DNA 序列。 PCR 由 Kary Mullis 于 1983 年开发，使研究人员能够在相对较短的时间内复製数百万个特定 DNA 片段。这个过程涉及重复的加热和冷却循环，促进 DNA 双螺旋的变性、引子与目标序列的退火以及 DNA聚合酵素对这些引子的延伸。反应混合物通常包括 DNA 模板、两种类型的引子、游离核苷酸、缓衝液和热稳定性 DNA聚合酵素，例如 Taq聚合酵素，可以承受变性所需的高温。这个循环过程以指数方式扩增目标 DNA 区域，使 PCR 成为基因研究、诊断和法医学中的重要工具。

PCR如何应用于各领域？

PCR因其能够快速且准确地扩增DNA而被广泛应用于各个科学和医学领域。在医疗诊断中，PCR 用于检测和量化细菌和病毒等病原体，从而识别 HIV、肝炎和 COVID-19 等感染疾病。基因检测也受益于 PCR，它可以识别与遗传性疾病相关的突变，并促进早期诊断和个人化治疗计划。在法医学领域，PCR 对于分析犯罪现场的微小 DNA 样本、提供将嫌疑人与犯罪活动联繫起来的证据至关重要。此外，PCR 在生物技术和製药行业的研究和开发中发挥重要作用，用于克隆、基因表现分析和基因改造生物的创建。 PCR 的多功能性和准确性使其成为增进对遗传学的理解以及改善公共卫生和安全的重要技术。

目前PCR技术和应用的趋势是什么？

在分子生物学的进步以及对快速、准确的遗传分析日益增长的需求的推动下，PCR 技术和应用不断发展。一个重要的趋势是定量 PCR (qPCR) 的发展，也称为即时PCR，它可以即时定量 DNA 或 RNA，从而提供有关基因表现和病毒量的宝贵见解。数位 PCR (dPCR) 是另一项创新，它透过将样本分成数千个单独的反应来提供更高的精度和灵敏度，从而实现核酸的绝对定量。微射流的进步促进了可携式PCR 设备的发展，使得在资源有限的环境和现场进行基因检测成为可能。此外，多重 PCR 可以在一次反应中扩增多个靶标，透过减少时间和试剂消耗来提高基因检测的效率。这些趋势反映了我们不断努力提高 PCR 的准确性、效率和可及性，扩大其在不同领域的潜在应用。

推动PCR市场成长的因素有哪些？

PCR 市场的成长是由多种因素推动的，这些因素反映了对先进基因分析和诊断工具的需求不断增长。医疗保健领域的扩展，特别是感染疾病的流行和早期诊断需求的增加，是PCR技术的重要驱动力。 qPCR 和 dPCR 等技术进步提高了 PCR 的功效和准确性，促进了其在各种应用中的采用。对个人化医疗的日益关注以及对准确基因检测来指南治疗决策的需求也推动了市场的成长。此外，生物技术和製药行业不断增加的研发活动正在推动药物发现和基因工程中对 PCR 的需求。 PCR 在法医学和环境监测中的使用越来越多，进一步支持了市场的扩张。 PCR 技术创新和改进的持续研发努力确保了 PCR 市场的强劲成长，凸显了 PCR 在推动分子生物学和改善公共卫生结果方面的重要作用。

受访企业范例（共17家）

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP14084

Global Polymerase Chain Reaction Market to Reach US$13.1 Billion by 2030

The global market for Polymerase Chain Reaction estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the PCR Reagents & Consumables segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.6% CAGR

The Polymerase Chain Reaction market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Polymerase Chain Reaction Market - Key Trends and Drivers Summarized

Polymerase Chain Reaction: A Cornerstone of Modern Molecular Biology

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of specific DNA sequences. Developed by Kary Mullis in 1983, PCR enables researchers to produce millions of copies of a particular DNA segment in a relatively short amount of time. The process involves repeated cycles of heating and cooling, which facilitate the denaturation of the DNA double helix, the annealing of primers to target sequences, and the extension of these primers by a DNA polymerase enzyme. Typically, the reaction mixture contains the DNA template, two primers, free nucleotides, a buffer solution, and the thermostable DNA polymerase, such as Taq polymerase, which can withstand the high temperatures required for denaturation. This cyclical process results in the exponential amplification of the target DNA region, making PCR an indispensable tool in genetic research, diagnostics, and forensic science.

How Is PCR Utilized Across Different Fields?

PCR is utilized extensively across various scientific and medical fields due to its ability to rapidly and accurately amplify DNA. In medical diagnostics, PCR is employed to detect and quantify pathogens, such as bacteria and viruses, enabling the identification of infections like HIV, hepatitis, and COVID-19. Genetic testing also benefits from PCR, as it can identify mutations associated with hereditary diseases, facilitating early diagnosis and personalized treatment plans. In the field of forensic science, PCR is crucial for analyzing minute DNA samples from crime scenes, providing evidence that can link suspects to criminal activities. Additionally, PCR plays a significant role in research and development within biotechnology and pharmaceutical industries, where it is used for cloning, gene expression analysis, and the creation of genetically modified organisms. The versatility and precision of PCR make it an essential technique for advancing our understanding of genetics and improving public health and safety.

What Are the Current Trends in PCR Technology and Applications?

The technology and applications of PCR are continuously evolving, driven by advancements in molecular biology and the increasing demand for rapid and accurate genetic analysis. One significant trend is the development of quantitative PCR (qPCR), also known as real-time PCR, which allows for the quantification of DNA or RNA in real-time, providing valuable insights into gene expression and viral load. Digital PCR (dPCR) is another innovation, offering higher precision and sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification of nucleic acids. Advances in microfluidics are leading to the creation of portable PCR devices, making it possible to conduct genetic testing in resource-limited settings or in the field. Additionally, multiplex PCR, which can amplify multiple targets in a single reaction, is enhancing the efficiency of genetic testing by reducing time and reagent consumption. These trends reflect the ongoing efforts to improve the accuracy, efficiency, and accessibility of PCR, expanding its potential applications in diverse fields.

What Factors Are Driving the Growth in the PCR Market?

The growth in the PCR market is driven by several factors, reflecting the increasing demand for advanced genetic analysis and diagnostic tools. The expansion of the healthcare sector, particularly the rising prevalence of infectious diseases and the need for early diagnosis, is a significant driver for PCR technology. Technological advancements, such as the development of qPCR and dPCR, are enhancing the capabilities and accuracy of PCR, encouraging its adoption in various applications. The growing focus on personalized medicine and the need for precise genetic testing to guide treatment decisions are also propelling market growth. Additionally, the rise in research and development activities within biotechnology and pharmaceutical industries is boosting the demand for PCR in drug discovery and genetic engineering. The increasing use of PCR in forensic science and environmental monitoring further supports market expansion. Continuous research and development efforts to innovate and improve PCR technologies ensure robust growth in the PCR market, underscoring its essential role in advancing molecular biology and improving public health outcomes.

Select Competitors (Total 17 Featured) -

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Polymerase Chain Reaction - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Molecular Diagnostics Propels Market Growth
    • Advances in PCR Technologies and Techniques Drives Adoption
    • Increasing Use in Infectious Disease Detection Expands Market Opportunities
    • Growth in Genetic and Genomic Research Strengthens Business Case for PCR
    • Development of Real-Time and Digital PCR Spurs Market Expansion
    • Expansion of Oncology and Cancer Research Generates Demand
    • Increasing Focus on Personalized Medicine Accelerates Market Growth
    • Enhanced Sensitivity and Specificity of Modern PCR Sustains Market Demand
    • Rising Investments in Biotechnology Research and Development Expands Addressable Market
    • Technological Innovations in PCR Reagents and Consumables Strengthens Market Position
    • Growth in Forensic and Clinical Applications Propels Market Growth
    • Increasing Demand for PCR in Agricultural and Food Testing Sustains Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Clinical Diagnostic Labs & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pharmaceutical & Biotechnology Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Polymerase Chain Reaction Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION